# The Effects of Preceding LPS Administration on the Fluenz-induced Immune Response

> **NCT02642237** · NA · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 30 (actual)

## Conditions studied

- Innate Immune Response
- Immune Tolerance

## Interventions

- **BIOLOGICAL:** Fluenz
- **OTHER:** placebo
- **OTHER:** LPS

## Key facts

- **NCT ID:** NCT02642237
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2017-01
- **Final completion:** 2018-02
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2019-05-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02642237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02642237, "The Effects of Preceding LPS Administration on the Fluenz-induced Immune Response". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT02642237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*